An interventional study of Internal mammary node irradiation in Breast Cancer, sponsored by Danish Breast Cancer Cooperative Group. Active, not recruiting. Per ClinicalTrials.gov, last updated 2024-08-12.
Sponsored by Danish Breast Cancer Cooperative Group · Not applicable, Interventional, and Treatment
The DBCG IMN study is a nationwide prospective population-based cohort study allocating node-positive breast cancer patients with right-sided tumors to internal mammary node irradiation (IMNI) and patients with left-sided tumors to no IMNI.
14,825 studies on the registry are indexed under Breast Neoplasms; 3,319 are open to participants now.
This study's enrollment of 7,630 is above the median of 72 across 10,896 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Danish Breast Cancer Cooperative Group is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumour. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adjuvant and neoadjuvant
Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumour. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with right-sided breast cancer tumors were allocated to internal mammary node irradiation.
Radiation: Internal mammary node irradiation
Patients with left-sided breast cancer tumors were allocated to no internal mammary node irradiation.
Irradiation of the internal mammary nodes in intercostal space 1-4.
Also known as: IMNI
Overall survival
Censored at end of study or by emigration.
Time frame: 15-years.
Breast cancer mortality
Censored at end of study or by emigration.
Time frame: 15-years.
Distant recurrences
Censored at end of study or by emigration. Death by any cause was regarded as competing event.
Time frame: 15-years.
No study locations are listed for this record.
Plan to share: Yes — Data may be requested at the DBCG RT committee and the DBCG board.
Time frame: Undecided.
Access criteria: DBCG board.
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Danish Breast Cancer Cooperative Group